Please ensure Javascript is enabled for purposes of website accessibility

Rite Aid to Open More COVID-19 Testing Sites in 7 States

By Eric Volkman – Apr 14, 2020 at 4:56PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The pharmacy chain operator aims to soon be capable of performing more than 5,000 tests a day.

Rite Aid (RAD -5.42%) is doing some of the heavy lifting to ramp up the nation's capacity to test for COVID-19, the disease caused by the SARS-CoV-2 coronavirus. The pharmacy chain operator announced Tuesday it is opening more drive-up COVID-19 testing sites at Rite Aid stores in seven states: New York, New Jersey, Connecticut, Pennsylvania, Ohio, Michigan, and Virginia.

Previously, the company was operating a single pilot testing site in Philadelphia.

Coronavirus.

Image source: Getty Images.

The first of the new testing operations, which will all be located in the stores' parking lots, has already been opened in Pennsylvania's capital of Harrisburg. The company expects to be able  to conduct 200 tests per day at that location. Testing will take place every day from 9 a.m. to 5 p.m. Testing at the other new locations should be up and running within several weeks, Rite Aid said.

In order to get tested, patients must pre-register on the company's website. Once at the site, self-swab nasal tests will be provided, with the sample-collection process monitored by company pharmacists. Patients will remain inside their vehicles for the duration.

Rite Aid said that to be tested, patients must meet criteria for testing set by the Centers for Disease Control and Prevention, and will be required to produce government-issued identification when on site. Those eligible will be given the tests free of charge.

The company is offering the tests as part of its partnership with the White House Coronavirus Task Force. Rite Aid said that in conjunction with that body "and with tremendous support from state and local officials, we will significantly expand COVID-19 testing to more than 5,000 tests daily in our country's key hot spots when fully operational."

The healthcare company's stock closed trading Tuesday up by 9.4%, well exceeding the 3.1% gains of the broader equities market as measured by the S&P 500 index.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Rite Aid Stock Quote
Rite Aid
RAD
$5.41 (-5.42%) $0.31

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
342%
 
S&P 500 Returns
110%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.